Symptomatic Carotid Artery Thrombosis in a Patient Recently Recovered From a COVID-19 Infection

Ilkin Bakirli1,2, Jan Tomka1,2, Marian Pis1,2

  • 1Vascular Surgery, National Institute of Cardiovascular Diseases, Bratislava, SVK.

Cureus
|October 18, 2021
PubMed

Insights

COVID-19 infection can cause arterial clots, including carotid thrombosis, even after recovery. This case highlights the need for prophylactic anticoagulation during and after COVID-19 illness.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Infectious Diseases

Background:

  • Coronavirus disease 2019 (COVID-19) is a global pandemic with known vascular complications.
  • While venous thrombotic events are common, arterial complications, particularly carotid thrombosis, are less understood.
  • Limited data exists on the association between COVID-19 and arterial thrombosis, especially in the carotid arteries.

Observation:

  • A 66-year-old male with hypertension presented with stroke symptoms (dysarthria, left-sided weakness).
  • Initial COVID-19 swab was negative, but CT angiography revealed thrombosis in the brachiocephalic trunk, right subclavian, and right common carotid arteries.
  • Lung imaging showed ground-glass opacities typical of COVID-19, and antibody testing confirmed a prior infection.

Findings:

  • The patient underwent successful carotid thrombectomy.
  • COVID-19 infection is implicated as a significant factor in carotid artery thrombosis due to inflammation, hypercoagulability, and hyperviscosity.
  • COVID-19 is identified as an independent risk factor for arterial thrombus formation, irrespective of disease severity.

Implications:

  • This case underscores the potential for COVID-19 to cause arterial thrombotic events, including stroke.
  • Prophylactic anticoagulation is recommended not only during acute COVID-19 illness but also in the early post-infection period.
  • Further research is needed to fully elucidate the mechanisms and long-term risks of COVID-19-associated arterial thrombosis.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
31
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
44
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
73
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
80
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
48
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
86